Systematic Comparison of Droplet-Based and Microwell-Based Platforms for Comprehensive Single-Cell Transcriptomic...

Area of Science:

• Genomics
• Bioinformatics
• Cancer Research

Background:

• Single-cell RNA sequencing (scRNA-seq) is a powerful tool in tumor research.
• Technical biases inherent to different scRNA-seq platforms can complicate data interpretation.
• Understanding these biases is critical for accurate analysis and cross-platform data integration.

Purpose of the Study:

• To compare the performance of droplet-based and microwell-based scRNA-seq platforms using clinical samples.
• To identify platform-specific technical biases affecting data analysis.
• To provide insights for optimizing platform selection and data integration in single-cell transcriptomics.

Main Methods:

• Comparative analysis of droplet- and microwell-based scRNA-seq platforms.
• Utilized clinical samples for assessing platform performance.
• Applied batch effect correction and analyzed differences in mRNA preference, cell type restoration, and gene expression patterns.

Main Results:

• Significant platform-dependent variations were observed despite batch effect correction.
• Droplet-based platforms showed higher immune cell capture, while microwell-based platforms offered more accurate immune cell representation.
• Differential gene expression, pseudotime, and cell-cell communication analyses highlighted platform-specific differences.

Conclusions:

• Platform selection significantly influences scRNA-seq data outcomes, particularly for immune cell analysis and gene expression.
• Awareness of platform-specific biases is essential for robust interpretation of tumor research data.
• Optimization strategies are needed for effective cross-platform data integration in single-cell transcriptomics.